Concepedia

V.Kate Hirst

VH

Statistics

Publications

9

Citations

919

H-Index

9

Active since

1983

Affiliations

Stanford University(Current)

Stanford Medicine

National Cancer Institute

University of Alberta

Washington University in St. Louis

V.Kate Hirst is an author at Stanford University specializing in medicine, oncology, and pharmacology.

Publications per year

1983–1996

9

Publications

9

SR-4233: A new bioreductive agent with high selective toxicity for hypoxic mammalian cells

Elaine M. Zeman, Jeremy Brown, Marilyn J. Lemmon et al. · International Journal of Radiation Oncology*Biology*Physics · 1986 · 395 citations

, , +8

Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cytotoxicity.

Martha Baker, Elaine M. Zeman, V.Kate Hirst et al. · PubMed · 1988 · 121 citations

, , +16

Enhancement of radiation-induced tumor cell killing by the hypoxic cell toxin SR 4233

Elaine M. Zeman, V.Kate Hirst, Marilyn J. Lemmon et al. · Radiotherapy and Oncology · 1988 · 95 citations

, , +14

Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508

C. Norman Coleman, Raul C. Urtasun, Todd H. Wasserman et al. · International Journal of Radiation Oncology*Biology*Physics · 1984 · 90 citations

, , +7

Mechanism of action of the selective tumor radiosensitizer nicotinamide

Michael R. Horsman, J. Martin Brown, D. Phil et al. · International Journal of Radiation Oncology*Biology*Physics · 1988 · 74 citations

, , +7

1–5 of 9